Skip to main content
. 2021 Dec 30;1253:132308. doi: 10.1016/j.molstruc.2021.132308

Table 6.

Hydroxyl radical scavenging activity of ligand acids and synthesized complexes.

Compound % Inhibition
Dose Conc. (µM)
15 30 60 120 240
HL1 10.00 ± 0.91 16.90 ± 2.21 22.70 ± 2.04 30.83 ± 2.53 42.87 ± 2.63
HL2 1.70 ± 0.20 3.54 ± 0.02 6.09 ± 1.06 9.99 ± 1.01 13.89 ± 1.21
1 13.90 ± 1.01 20.78 ± 2.04 30.55 ± 2.56 44.99 ± 2.57 71.78 ± 2.48
2 2.95 ± 0.07 5.98 ± 0.97 8.09 ± 1.08 9.00 ± 1.78 11.02 ± 1.01
Vit C 17.56 ± 1.05 27.99 ± 2.45 32.76 ± 2.79 49.76 ± 2.87 76.78 ± 2.78
HHS Vulnerability Disclosure